Neuphoria Therapeutics Inc. · NASDAQ:NEUP
Apeiron Investment Group Ltd. reported a 4.50% stake in Neuphoria Therapeutics Inc. (Schedule 13D/A)
Event Jan 24, 2025 · Filed Jan 28, 2025
Apeiron Investment Group Ltd. reported a 4.50% stake in Neuphoria Therapeutics Inc., 72,618 shares, with active intent on Jan 24, 2025. Filed Jan 28, 2025 (Schedule 13D/A).
- Stake
- 4.50%
- Shares
- 72,618
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Apeiron Investment Group Ltd. | 4.50% | 72,618 |
| Apeiron Presight Capital Fund II, L.P. | 0% | 0 |
| Presight Capital Management I, L.L.C. | 0% | 0 |
| Fabian Hansen | 0% | 0 |
| Christian Angermayer | 4.50% | 72,618 |
Source
Related
- Neuphoria Therapeutics Inc.
- Apeiron Investment Group Ltd.
- Neuphoria Therapeutics Inc. shareholders
- Schedule 13G · AdvisorShares Trust · Oct 5, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 28, 2026
- Schedule 13G/A · Baselake Partners, LP · Feb 6, 2026
- Schedule 13D/A · Lynx1 Capital Management LP · Dec 29, 2025
- Schedule 13D/A · Lynx1 Capital Management LP · Dec 2, 2025